Salesforce Inc (NYSE: CRM) Has Another Chance To Impress You

Currently, there are 956.00M common shares owned by the public and among those 931.84M shares have been available to trade.

The company’s stock has a 5-day price change of 0.62% and 39.04% over the past three months. CRM shares are trading 33.38% year to date (YTD), with the 12-month market performance up to 34.16% higher. It has a 12-month low price of $212.00 and touched a high of $369.00 over the same period. CRM has an average intraday trading volume of 6.02 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.75%, 9.91%, and 25.16% respectively.

Institutional ownership of Salesforce Inc (NYSE: CRM) shares accounts for 81.46% of the company’s 956.00M shares outstanding.

It has a market capitalization of $335.88B and a beta (3y monthly) value of 1.31. The stock’s trailing 12-month PE ratio is 57.74, while the earnings-per-share (ttm) stands at $6.08. The company has a PEG of 3.50 and a Quick Ratio of 1.01 with the debt-to-equity ratio at 0.21. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.47% over the week and 2.42% over the month.

Earnings per share for the fiscal year are expected to increase by 22.13%, and 12.01% over the next financial year. EPS should shrink at an annualized rate of 16.50% over the next five years, compared to 24.06% over the past 5-year period.

Looking at the support for the CRM, a number of firms have released research notes about the stock. KeyBanc Capital Markets stated their Overweight rating for the stock in a research note on December 13, 2024, with the firm’s price target at $440. Macquarie coverage for the Salesforce Inc (CRM) stock in a research note released on December 12, 2024 offered a Neutral rating with a price target of $370. BMO Capital Markets was of a view on December 04, 2024 that the stock is Outperform, while Scotiabank gave the stock Sector Outperform rating on November 19, 2024, issuing a price target of $425. BMO Capital Markets on their part issued Outperform rating on November 15, 2024.

Most Popular

Related Posts